Artificial intelligence is reshaping the landscape of research, and drug discovery and development are not spared. The integration of AI-driven technologies does raise key questions. From target identification to clinical trials, how does AI concretely transform the R&D of life sciences today? How have companies chosen to leverage AI-driven technologies in their R&D strategies? What hurdles are R&D teams currently facing when working with AI? What challenges remain in technology implementation, cultural transition, ethical considerations? Beyond drug discovery, how far can AI influence the ways of the sector? As AI continues to evolve, how should biotech and pharma players prepare for the next wave of innovation?

Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.